Suchergebnisse - "Sun, Chaoyang"

PubPharm (11)

1

Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study) : a multicentre, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Li, K. | Chen, J. | Hu, Y. | +24

2

Melatonin provides protection against cisplatin-induced ovarian damage and loss of fertility in mice

enthalten in: Reproductive biomedicine online | 2021

von Huang, J. | Shan, W. | Li, N. | +12

3

A reactive oxygen species scoring system predicts cisplatin sensitivity and prognosis in ovarian cancer patients

enthalten in: BMC cancer | 2019

von Sun, C. | Guo, E. | Zhou, B. | +13

ErratumIn: BMC Cancer. 2020 Mar 12;20(1):210. - PMID 32164614

4

Clarithromycin synergizes with cisplatin to inhibit ovarian cancer growth in vitro and in vivo

enthalten in: Journal of ovarian research | 2019

von Zhou, B. | Xia, M. | Wang, B. | +7

5

Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways

enthalten in: International journal of oncology | 2016

von Zhou, B. | Sun, C. | Li, N. | +10

6

HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells

enthalten in: Oncology research | 2016

von Lu, H. | Sun, C. | Zhou, T. | +11

7

Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer : involvement of STAT3 signaling

enthalten in: The FEBS journal | 2015

von Yang, Z. | Liu, Y. | Liao, J. | +8

ErratumIn: FEBS J. 2019 Dec;286(24):5030-5031. - PMID 31860789

8

Suppression of ATR reverses the cisplatin resistance in ovarian cancer SKOV3 cells

enthalten in: Zhonghua zhong liu za zhi [Chinese journal of oncology | 2014

von Yang, Z. | Sun, C. | Liu, Y. | +3

9

Low concentration of quercetin antagonizes the cytotoxic effects of anti-neoplastic drugs in ovarian cancer

enthalten in: PloS one | 2014

von Li, N. | Sun, C. | Zhou, B. | +4

10

miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition

enthalten in: Journal of the National Cancer Institute | 2013

von Sun, C. | Li, N. | Yang, Z. | +10